- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- September 2023
- 141 Pages
Global
From €2162EUR$2,250USD£1,848GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- March 2024
- 183 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- March 2024
- 185 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- March 2024
- 188 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- May 2024
- 196 Pages
Global
From €4756EUR$4,950USD£4,066GBP
- Report
- May 2024
- 915 Pages
Global
From €5237EUR$5,450USD£4,477GBP
- Report
- November 2023
- 130 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- November 2023
- 180 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- May 2023
- 160 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- March 2024
- 146 Pages
Global
From €3746EUR$3,899USD£3,203GBP
- Report
- November 2023
- 140 Pages
Global
From €2401EUR$2,499USD£2,053GBP
- Report
- October 2023
- 148 Pages
Global
From €2401EUR$2,499USD£2,053GBP
- Report
- February 2024
- 75 Pages
Global
From €4756EUR$4,950USD£4,066GBP
- Report
- July 2023
- 55 Pages
Global
From €2354EUR$2,450USD£2,013GBP
- Report
- February 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- February 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- November 2023
- 190 Pages
Global
From €4708EUR$4,900USD£4,025GBP
The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more